Skip to main content
. 2020 May 8;146(9):2427–2433. doi: 10.1007/s00432-020-03239-1

Fig. 1.

Fig. 1

Flowchart of patient selection in the molecular analysis set. NSCLC non-small-cell lung cancer, PD progressive disease, SCLC small-cell lung cancer